Maternal Vitamin D, Folate, and Polyunsaturated Fatty Acid Status and Bacterial Vaginosis during Pregnancy by Dunlop, Anne L. et al.
Hindawi Publishing Corporation
Infectious Diseases in Obstetrics and Gynecology
Volume 2011, Article ID 216217, 7 pages
doi:10.1155/2011/216217
Research Article
Maternal VitaminD, Folate, and Polyunsaturated Fatty Acid
Status andBacterial VaginosisduringPregnancy
AnneL.Dunlop,1 Robert N. Taylor,2 VinTangpricha,3
Stephen Fortunato,4 and Ramkumar Menon5
1Department of Family & Preventive Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
2Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30322, USA
3Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322, USA
4Perinatal Research Center, Women’s Health Research and Education Foundation, Nashville, TN 37203-1538, USA
5Division of Maternal-Fetal Medicine Perinatal Research, Department of Obstetrics & Gynecology,
The University of Texas Medical Branch at Galveston, Galveston, TX 77555-1062, USA
Correspondence should be addressed to Anne L. Dunlop, amlang@emory.edu
Received 22 August 2011; Accepted 25 October 2011
Academic Editor: Michael G. Gravett
Copyright © 2011 Anne L. Dunlop et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
Objective. To investigate associations among serum 25-hydroxy-vitamin D (25-OH-D), folate, omega-6/omega-3 fatty acid ratio
and bacterial vaginosis (BV) during pregnancy. Methods. Biospecimens and data were derived from a random sample (N = 160)
of women from the Nashville Birth Cohort. We compared mean plasma nutrient concentrations for women with and without BV
duringpregnancy(basedonNugentscore ≥7)andassessedtheoddsofBVforthosewith25-OH-D<12ng/mL,folate<5ug/L,and
omega-6/omega-3ratio>15.Results.Themeanplasma25-OH-DwassigniﬁcantlyloweramongwomenwithBVduringpregnancy
(18.00±8.14ng/mLversus24.34±11.97ng/mL, P = 0.044).Theadjustedoddsof BVwere signiﬁcantlyincreasedamongpregnant
womenwith25-OH-D<12ng/mL(aOR5.11,95%CI:1.19–21.97)andfolate<5ug/L(aOR7.06,95%CI:1.07–54.05).Conclusion.
Vitamin D and folate deﬁciencies were strongly associated with BV (Nugent score ≥7) during pregnancy.
1.Introduction
Bacterial vaginosis (BV), a polymicrobial clinical syndrome
resulting from replacement of the normal vaginal ﬂora with
high concentrations of anaerobic bacteria [1], commonly
aﬀects women of reproductive age in the United States [2, 3].
BV is associated with adverse gynecologic and obstetrical
outcomes. Among nonpregnant women, BV is associated
with endometritis [4], postabortion endometritis [5], and
nonchlamydial-nongonococcal pelvic inﬂammatory disease
[6]. BV also increases a woman’s risk of acquiring and
transmitting HIV infection [7–13] and is associated with
increased prevalence of herpes simplex virus 1 and 2 [14]
as well as Neisseria gonorrhoeae and Chlamydia trachomatis
infection[15].PregnantwomenwithBVareatincreasedrisk
of premature rupture of the fetal membranes [16], chori-
oamnionitis and intra-amniotic infection [17], postcesarean
delivery endometritis [18], postpartum complications of the
infant [19], and spontaneous preterm birth [20–24]. Ran-
domized controlledtrialsamongwomenwhohadpreviously
experienced a spontaneous preterm birth show a reduction
in the recurrence of preterm birth following treatment of BV
[25]. It is estimated that the signiﬁcantly higher rates of BV
among black women may account for up to one-third of the
black-white racial disparity in preterm birth in the United
States [26].
Theetiology ofandrisk factorsforBVarenot completely
understood. A recent cohort study found that black race,
cigarette smoking, vaginal intercourse, receptive anal inter-
course before vaginal intercourse, sex with an uncircumcised
male partner, and the presence of herpes simplex virus 2
antibodies are independently associated with the acquisition
of BV [27]. BV is three times more prevalent among
black compared with white women [2], but factors such as2 Infectious Diseases in Obstetrics and Gynecology
socioeconomic status, more frequent douching, and sexual
intercourse, and other recognized risk factors for BV do not
account for the racial disparity [2, 28].
It is theorized that factors that impair the immune sys-
tem, including micronutrient deﬁciencies, may increase
susceptibility to BV. One US cohort study has examined the
association between maternal vitamin D status and BV in
pregnancy, ﬁnding a dose-response relationship between the
mean unadjusted serum 25-OH-D concentration and the
prevalence of BV per Gram stain of vaginal smears obtained
in early pregnancy [29]. National Health and Nutrition
Examination Survey (NHANES) data from 2001–2004 reveal
that vitamin D deﬁciency is associated with BV in pregnant,
butnot nonpregnant, women(aOR2.87, 95% CI: 1.13–7.28)
[30]. Another US cohort study among nonpregnant women
found an association between BV and the high total dietary
intake of fat (aOR 1.5, 95% CI: 1.1–2.4) and the low dietary
intake of folate (aOR 0.4, 95% CI: 0.2–0.8), vitamin E (aOR
0.4, 95% CI: 0.2–0.8), and calcium (aOR 0.4, 95% CI: 0.3–
0.7), whereas no relationship with dietary vitamin D intake
was observed [31]. A cohort study of low-income, pregnant
African-American women found no association between BV
and dietary intake of protein and vitamins A and C [32].
A case-control study of well-nourished pregnant Belgian
women found a signiﬁcantly increased risk of BV among
women with subclinical iron deﬁciency [33].
Existing studies of micronutrient status and BV during
pregnancy have concluded that replication of these ﬁnd-
ings in other study populations, especially those that are
racially heterogeneous, is important for further investigating
the potential relationship between maternal micronutrient
status and BV during pregnancy. The purpose of this study
wastoexplorewhethermaternalserumconcentrationsof25-
OH-D, folate, and omega-6/omega-3 polyunsaturated fatty
acids were associated with the diagnosis of BV (Nugent score
≥7) during the pregnancy.
2.MaterialsandMethods
2.1. Overview. T h es u b j e c t sf o rt h i ss t u d yw e r ed r a w nf r o m
women enrolled in the Nashville Birth Cohort as part of an
on-going genetic study of racial disparities in spontaneous
preterm birth at Centennial Women’s Hospital, Nashville,
Tenn, USA, a tertiary care hospital that receives referrals and
transfers of high-risk patients from an area that encompasses
a 100 mile radius around Nashville [34]. This study involved
the biochemical assessment of vitamin D, folate, and polyun-
saturated fatty acid status from stored EDTA plasma samples
collected during the delivery admission and comparison of
vitamin D, folate, and polyunsaturated fatty acid nutriture
for women with and without a diagnosis of BV during the
pregnancy.
The study was approved by the Western Institutional
Review Board. All patient participants provided written
informedconsentatthetimeofenrollment;theconsentform
speciﬁcally sought permission to store biosamples for future
testing and research. The Emory University Institutional
Review Board also approved the study protocol (no. 31456).
2.2. Study Sample. Biospecimens and medical record data
for this study (N = 160) reﬂect a subsample of the 1,547
total women enrolled into the Nashville Birth Cohort during
2003–2006. Using a stratiﬁed random sampling strategy
based upon computer-generated random number selection,
80 women (40 non-Hispanic black and 40 non-Hispanic
white) with spontaneous preterm birth and 80 women
(40 non-Hispanic black and 40 non-Hispanic white) with
term birth were selected from among those for whom
suﬃcient stored plasma samples were available for planned
biochemical analyses. This project examined samples from
160 women as we had suﬃcient funding to perform the
biochemical assessments for this number of subjects.
Criteria for enrollment into the Nashville Birth Cohort
included being a woman ≥18 years at the time of the
delivery admission who was pregnant, nulli- or primiparous
upon enrollment with a singleton infant without anomalies.
Women with multiple gestations, preeclampsia, placenta
previa, fetal anomalies, medical/surgical complications of
pregnancy, and drug or alcohol abuse were excluded.
Preeclampsiawasdeﬁnedasabloodpressureontwoseparate
readings taken at least 4 hours apart of 140/90 or more and
≥300mg of protein in a 24-hour urine sample (proteinuria).
Subjects who had any surgical procedures during pregnancy
or who were treated for preterm labor or for suspected
intraamniotic infection and delivered at term were excluded.
2.3. Clinical Data. Clinical data obtained from the Nashville
Birth Cohort were used for this study, including the follow-
ing.
(1) Gestational Age. The gestational age at delivery was
ascertained by review of the prenatal records. Both the last
menstrual period and ultrasound before the 20th week of
gestation were used to assign gestational age. If the last
menstrualperiodandultrasoundresultswerediscordant,the
ultrasound result was used, according to accepted clinical
criteria.
(2) Obstetrical History and Pregnancy Outcome. Information
related to the number of prior pregnancies and births and
the outcomes of pregnancies and births was ascertained via
review of the prenatal record (which included an obstetrical
interview conducted at the ﬁrst prenatal visit). Using the
gestational age of the index pregnancy, the deliveries were
dichotomized as preterm (22-0/7 through 36-6/7 weeks) or
term (≥37 weeks).
(3) Maternal Race/Ethnicity. Maternal race was self-iden-
tiﬁed based on the race/ethnicity of their own parents and
grandparents. Those who identiﬁed as being of Hispanic
ethnicity, as well as those of mixed race, and those who
were unsure of the race/ethnicity of their parents and
grandparents were excluded from this study. Those who
identiﬁed each of their parents and grandparents as black
were regarded as black for this study, and similarly for whites
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(4) Body Mass Index (BMI). Prepregnancy BMI was cal-
culated from measured height at the ﬁrst prenatal visit
and patients’ report of their Prepregnancy weight at the
ﬁrst prenatal visit. BMI was categorized according to
accepted deﬁnitions (obesity ≥30kg/m2, overweight 25–
29.99kg/m2, healthy weight 18.5–24.99kg/m2,a n du n d e r -
weight <18.5kg/m2).
(5) Bacterial Vaginosis. Women enrolled into the cohort at
Centennial Women’s Hospital received prenatal care through
obstetrical care providers who follow a clinical protocol that
involves performing a pelvic speculum examination at the
initial obstetrical visit to ascertain for the presence of BV
according to Nugent’s criteria. Vaginal swabs from the pelvic
examination were transported to the clinical pathology lab-
oratory at Centennial Women’s Hospital for Gram staining
and determination of BV according to Nugent’s criteria, with
as c o r e≥7c o n s i d e r e dp o s i t i v e[ 35].
2.4. Biological Specimens and Nutrient Analyses. Blood sam-
ples were obtained at the time of the delivery admission
for all consented subjects. Nonfasting venous blood drawn
routinely as part of the delivery admission was obtained, and
an extra aliquot of EDTA plasma was centrifuged and stored
at −80◦C degrees. Thawed EDTA plasma was analyzed for
the following nutrients, and measurements were categorized
as described below. All assays were performed by technicians
without knowledge of case-control status.
(1) Vitamin D. Plasma 25-OH-D concentration, the major
circulating form of vitamin D, was assayed using a com-
mercially available ELISA kit (Immunodiagnostic Systems,
Fountain Hills, AZ), the range of detection for which is
2–120ng/mL. Analyses were performed at the Vitamin D
and Bone Research Laboratory at Emory University School
of Medicine, which participates in the vitamin D external
quality assessment scheme (http://www.deqas.org/) and in
the National Institutes of Health/National Institute of Stan-
dards and Technology (NIH/NIST) Vitamin D Metabolites
Quality Assurance Program (VitDQAP) to ensure accuracy
of the 25-OH-D measurements. In accordance with a
recent review of data by a committee of the Institute of
Medicine, the following serum concentrations of 25-OH-
D were considered in the analyses: <12ng/mL (vitamin D
deﬁcient),12–20ng/mL(vitaminDinsuﬃcient), ≥20ng/mL
(referrentcategory, considered adequate for bone and overall
health in healthy individuals) [36].
(2) Folate. Plasma folate concentration was measured by
competitive-binding chemiluminescent radioimmunoassay
using competitive displacement of 125-I folic acid from
intrinsic factor and folate binding proteins immobilized
on microcrystalline cellulose. Analyses were performed by
Emory Healthcare laboratory, an accredited clinical and
researchlaboratoryusingaBeckmanCoulterDX1800(Beck-
man Coultern, Inc., Fullerton, Calif). Folate deﬁciency was
deﬁned as a measured serum concentration <5ug/L [37].
(3) Omega-6 and Omega-3 Fatty Acids. Fatty acid analyses
were performed in the Lipoprotein Analysis Laboratory,
Wake Forest University School of Medicine. In brief, the total
lipid fraction was extracted from 100uL of plasma, and the
phospholipidfractionwasisolatedbyliquidchromatography
on silica gel plates. Fatty acid methyl esters were prepared by
transesteriﬁcation involving saponiﬁcation with 0.5 NaOH
in methanol and methylation using 14% BF3 in methanol
followedbyextractioninhexane.Thefattyacidmethylesters
were separated via capillary column gas chromatography
and identiﬁed by ﬂame ionization. Retention times were
determined with mixed fatty acid methyl ester standards
from NuChek Prep (Elysian, Minn), and quantiﬁcation by
comparison with the peak areas of the internal standards
providedabsoluteconcentrations[38].Polyunsaturatedfatty
acids were expressed as a ratio of total omega-6 to omega-3
fatty acids. Presently, there is not a deﬁned cut-point for an
excessive omega-6/omega-3 fatty acid ratio; in this study, the
highest tertile was a ratio of omega-6/omega-3 >15, and this
was used to categorize the data.
2.5. Data Analysis. We compared demographic and clinical
characteristics of women with and without BV using Stu-
dent’s t-test for continuous measures and Pearson’s Chi-
square or Fisher’s exact test for categorical measures. We
compared the mean concentrations of plasma 25-OH-D and
folate and the mean ratio of total omega-6/omega-3 fatty
acids for women with and without BV using Student’s t-test.
We compared the proportion of women with and without
BV who had plasma 25-OH-D <12 and <20ng/mL, folate
<5ug/L, and total omega-6/omega-3 fatty acid ratio >15
usingPearson’sChi-squaretest.Westratiﬁedthecomparison
of BV × black versus white race, obese versus nonobese
status and nutrient status, assessing for biological interaction
using the Breslow-Day test statistic. We used multivariate
logistic regression to assess the independent and interactive
eﬀects of the nutrient measures in separate models that
included covariates noted to be linked with BV in previous
research, including age, race, obesity, health insurance status,
maritalstatus,andsmokingstatus.Allhypothesistestingand
reported probability values were two-tailed and conductedat
the α = 0.05 level. Statistical analyses were conducted using
SPSS 17.0 (SPSS, Inc.).
3. Results
Among the study sample, 14/146 (8.8%) of women were
diagnosed with BV (Nugent Score ≥7) during the pregnancy.
Characteristics of women with and without BV during the
pregnancy are given in Table 1. There was no signiﬁcant
diﬀerence in the mean maternal age, years of education,
BMI, or gestational age at delivery among women with and
without BV during the pregnancy. Of the nutrients under
study, there was a signiﬁcant diﬀerence in the mean plasma
concentration of 25-OH-D for women with and without BV
during the pregnancy (18.00 ± 8.14ng/mL versus 24.34 ±
11.97ng/mL, P = 0.044). The mean plasma concentration of
folate and the mean ratio of omega-6/omega-3 polyunsatu-
ratedfattyacidsweregreateramongthosewithBVcompared4 Infectious Diseases in Obstetrics and Gynecology
Table 1: Characteristics of women with and without bacterial vagi-
nosis during pregnancy.
Characteristic
Bacterial
vaginosis during
pregnancy
(n = 14)
No bacterial
vaginosis during
pregnancy
(n = 146)
P value
Maternal age—mean
years (sd) 24.14 ± 6.04 26.13 ± 6.06 0.946
Education—mean
years (sd) 13.57 ± 2.56 13.80 ± 2.60 0.904
BMI—kg/m2 (sd) 27.25 ± 8.87 25.99 ± 6.63 0.135
Gestational age at
delivery—weeks (sd) 34.90 ± 3.37 36.62 ± 2.99 0.086
25-OH-D
(ng/mL)—mean (sd) 18.00 ± 8.14 24.34 ± 11.97 0.044
Folate (ug/L)—mean
(sd) 7.9 ± 5.1 10.7 ± 4.6 0.086
Omega-6/omega-3
ratio—mean (sd) 13.8 ± 3.4 13.0 ± 2.5 0.265
to those without BV during the pregnancy, but diﬀerences
were not signiﬁcant (Table 1).
The proportion of women with particular characteristics
and who had measured nutrient values outside the cut-
oﬀ values of interest, along with the crude and adjusted
odds of BV for women with these characteristics, is given
in Table 2. In neither univariate or multivariate analysis was
black race, being a teenager, obesity, or medicaid status
associated with BV. In multivariate analysis, the odds of BV
were signiﬁcantly greater among smokers (aOR 3.16, 95%
CI: 1.08–10.21). In both univariate and multivariate analysis,
25-OH-D <12ng/mL and folate <5ug/L increased the odds
of BV during pregnancy. Conversely, omega-6/omega-3 ratio
>15 was not signiﬁcantly associated with BV in univariate or
multivariate analysis. Stratiﬁed analyses revealed no impor-
tant biological interactions for the relationship between BV
and the nutrients of interest according to race or obesity
status.
4. Discussion
In this study, we observed a signiﬁcantly lower mean plasma
concentration of 25-OH-D among women diagnosed versus
not diagnosed with BV during pregnancy as well as a
signiﬁcant association between maternal serum 25-OH-D
<12ng/mL and folate <5ug/mL and the occurrence of BV
during pregnancy. In the case of vitamin D deﬁciency, our
ﬁndings are consistent with a recent cohort of pregnant
women, which found a dose-response relationship between
25-OH-D and the prevalence of BV during pregnancy
[29], and a nationally representative cross-sectional study
of women in the United States, which found that 25-
OH-D <30ng/mL signiﬁcantly increased the odds of BV
during pregnancy (aOR 2.87, 95% CI: 1.13–7.28) [30].
However, it is notable that, in our study, the odds of BV
were only signiﬁcantly greater for women with a serum 25-
OH-D <12ng/mL and not for those with serum 25-OH-D
<20ng/mL. In the case of folate deﬁciency, our ﬁndings are
consistent with a prior cohort study ﬁnding of a relationship
between low-dietary folate intake and BV, although that
studywasamongnonpregnantwomenandexamineddietary
intake as opposed to plasma folate concentration [31].
Existing research supports that micronutrient status
is linked with susceptibility to infection, lending biologic
plausibility to the observed associations between maternal
nutrient status and BV during pregnancy. The active form of
vitamin D (1,25-dihydroxyvitamin D3) is a key modulator of
theimmuneresponse,andvitaminDisknowntobeapotent
regulator of placental immunity, stimulating antimicrobial
responses while suppressing inﬂammation [39]. There is
emerging evidence that vitamin D regulates a key antimi-
crobial peptide with broad antimicrobial properties against
gram-negative and gram-positive bacteria [40]. Adequate
vitamin D status may oﬀer protection against BV by
induction of cathelicidin [41]. Low serum folate is associated
with impaired T cell and neutrophil function, and deﬁciency
of folate is associated with an increased risk of bacteriuria in
pregnancy [42–44].
Studies in the US demonstrate a higher prevalence of
deﬁciencies of vitamin D and folate among black compared
with white women. Circulating levels of 25-OH-D are a
direct reﬂection of total body vitamin D status, which
depends upon access to vitamin D either through exposure
to sunlight or dietary intake. NHANES data from 1988–
1994 reveal that 42% of non-Hispanic black women of child-
bearing age had 25-OH-D levels lower than 37.5nmol/L
(15ng/mL) compared with only 4% of non-Hispanic white
women [45]. Also, suboptimal vitamin D status, deﬁned
as 25-OH-D <75nmol/L (30ng/mL), is more prevalent
among non-Hispanic black compared with non-Hispanic
white women (74–95% versus 46–62%) [46]. According to
2001-2002 NHANES data, non-Hispanic black women have
lower folate intake from both food and supplement sources.
Whereas approximately 40% of non-Hispanic white women
consume400ugoffolicdaily,only5%ofnon-Hispanicblack
women achieve 400ug of folic acid daily from fortiﬁed foods
and supplements. The prefortiﬁcation mean red blood cell
folate was lower for non-Hispanic black compared with non-
Hispanic white women, and fortiﬁcation produced a smaller
shift in mean red blood cell folate levels for black compared
with white women [47].
Existing studies also clearly demonstrate signiﬁcantly
higher rates of BV among black compared with white
women and estimate that the signiﬁcantly higher rates of
BV among black women may account for up to one-third
of the black-white racial disparity in preterm births [26].
Thus, in addition to the myriad other health reasons for
addressingthepoorunderlyingvitaminDandfolatestatusof
US women [48, 49], decreasing the susceptibility of women
of reproductive age to BV may provide further rationale.
Strengths of this study include its use of the microbi-
ologic gold standard for the determination of BV and its
use of biochemical assessment of nutrient status. Another
strength is that pregnant women who entered the birthInfectious Diseases in Obstetrics and Gynecology 5
Table 2: Crude and adjusted odds for bacterial vaginosis during pregnancy according to maternal characteristics.
Characteristic Bacterial vaginosis (n = 14) No bacterial vaginosis (n = 146) cOR (95% CI) aOR (95% CI)∗
Black race (%) 8 (57.1%) 72 (49.3%) 1.37 (0.45, 4.15) 1.17 (0.36, 3.76)
Teenager (%) 4 (28.6%) 19 (13.0%) 2.67 (0.76, 9.39) 2.27 (0.53, 9.79)
Smoker (%) 6 (42.9%) 31 (21.2%) 2.78 (0.92, 8.61) 3.16(1.08, 10.21)
Obese (%) 4 (30.8%) 40 (27.8%) 1.16 (0.34, 4.01) 1.33 (0.36, 4.92)
Delivery <37 weeks (%) 10 (71.4%) 70 (47.9%) 2.71 (0.87, 9.05) 1.96 (0.64, 7.10)
TennCare∗∗ (%) 8 (57.1%) 74 (50.7%) 1.16 (0.78, 3.85) 1.79 (0.31, 10.32)
Folate <5ug/L—n (%) 3 (21.4%) 4 (4.0%) 6.55 (1.29, 33.13) 7.06(1.07, 54.05)
25-OH-D <12ng/mL—n (%) 5 (35.7%) 10 (6.8%) 7.58 (2.13, 27.03) 5.11(1.19, 21.97)
25-OH-D <20ng/mL—n (%) 7 (50%) 62 (42.5%) 1.4 (0.5, 4.1) 1.2 (0.39, 3.85)
Omega-6/omega-3 > 15—n (%) 12 (85.7%) 92 (65.2%) 3.19 (0.79, 14.93) 3.98 (0.78, 13.7)
∗The multivariate model included race, age, smoking status, body mass index status, gestational age at delivery, and payor source.
∗∗Tennessee’s Medicaid Managed Care Program that provides health insurance coverage for low-income, pregnant women.
cohortwereassessedforBVupontheirinitialobstetricalvisit
regardless of their symptom status, thereby increasing the
generalizability of our study ﬁndings.
The present study is not without limitations. First,
the measurement of serum nutrient status occurred upon
admission to the labor and delivery unit, thereby limiting
our ability to evaluate the potential importance of peri-
conception and early pregnancy nutritional status and BV.
While this may have contributed to our ﬁndings, previous
longitudinal research documents that maternal fatty acid
values remain constant throughout pregnancy [50] and 25-
OH-D concentrations do not diﬀer signiﬁcantly throughout
gestation [51, 52]. Second, because subjects were enrolled
during their delivery admission with spontaneous onset of
labor, we were restricted to the use of Nonfasting samples.
The use of Nonfasting specimens could have inﬂuenced our
ﬁndings; however, a previous study that assessed prenatal
dietary intake and Nonfasting plasma fatty acids found high
correlations between fasting and postprandial plasma lipid
measures (ranging from 0.90 to 0.99, P<0.001) [53].
Anotherlimitationisthat,duetohavingaccesstoonlystored
plasma, we were able to measure circulating folate and fatty
acids but not intracellular erythrocyte folate and fatty acid
concentrations. Red blood cell measures of these nutrients
provide a more stable and reliable measure of nutrient
status over several months [54, 55]. However, previous
researchdemonstratesveryhighcorrelationsbetweenplasma
and red blood cell folate and fatty acids [56, 57]. A ﬁnal
limitation is that a relatively small proportion of women in
the study sample met Nugent’s criteria for the diagnosis of
BV, thereby limiting the power of the study for detecting
the assessing of the relationship of the nutrients with BV.
It is possible that, had the study protocol called for repeat
testing for BV throughout the pregnancy, whether women
weresymptomaticornot,thatahigherproportionofwomen
in the sample may have met criteria for the diagnosis of BV
in pregnancy.
5. Conclusions
This case-control study found a signiﬁcant association
between maternal plasma 25-hydroxy-vitamin D <12ng/mL
and folate <5ug/mL and BV during pregnancy. Given the
growing evidence that pregnant women with BV are at
increased risk of a number of adverse pregnancy outcomes,
including spontaneous preterm birth, prospective research
studies that assess nutrient status and BV prevalence early
in pregnancy, identify incident cases of BV during the
pregnancy, and assess the role of supplementation on BV
prevalence and incident cases as well as on important
pregnancy outcomes are needed to reﬁne our understanding
of the role of micronutrients in infectious and pregnancy-
related outcomes.
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